**Author details**

Jorge Andrade-Sierra1,2,3\*, Pedro Alejandro Vazquez-Galvan2 , Hernesto Hernandez-Reyes2 , Lydia A. Mercado-Jáuregui3 , Jonathan S. Chávez-Iñiguez4 , Eduardo González-Espinoza2 , Benjamin Gómez-Navarro2 and José I. Cerrillos-Gutiérrez2

[8] Terasaki PI. A personal perspective: 100-year history of the humoral theory of transplan-

Immunosuppressive Minimization Strategies in Kidney Transplantation

http://dx.doi.org/10.5772/intechopen.77292

367

[9] Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Current Opinion

[10] Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nature Reviews

[11] Wiebe C, Gibson IW, Blydt-Hansen TD, et al. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.

[12] Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. American

[13] Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss.

[14] Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation. 2010;**90**(1):68-74 [15] Cantarovich D, Hodemon-Corne B, Trebern-Launay K, Giral M, Foucher Y, Dantan E. Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetes. Transplantation Proceed-

[16] Woodle ES, Peddi VR, Tomlanovich S, Mulgaonkar S, Kuo PC, Investigators TS. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with thymoglobulin in living-donor kidney transplantation. Clinical Transplantation. 2010;**24**(1):

[17] Andrade-Sierra J, Rojas-Campos E, Cardona-Munoz E, et al. Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia. 2014;**34**(2):216-222

[18] Rike AH, Mogilishetty G, Alloway RR, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid with-

[19] Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk: A meta-analysis.

[20] Pascual J, Quereda C, Zamora J, Hernandez D, Spanish Group for Evidence-Based Medicine in Renal T. Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplantation Proceedings.

[21] Gonzalez-Molina M, Gentil MA, Burgos D, et al. Effect of long-term steroid withdrawal in renal transplant recipients: A retrospective cohort study. NDT Plus. 2010;

drawal and chronic steroids. Clinical Transplantation. 2008;**22**(2):229-235

American Journal of Transplantation. 2015;**15**(11):2921-2930

tation. Transplantation. 2012;**93**(8):751-756

Journal of Transplantation 2012;**12**(2):388-399

in Immunology. 2005;**17**(5):541-545

Immunology. 2005;**5**(10):807-817

Lancet. 2011;**378**(9800):1428-1437

ings. 2013;**45**(4):1497-1502

Transplantation. 2010;**89**(1):1-14

2005;**37**(9):3746-3748

**3**(Suppl\_2):ii32-ii36

73-83

\*Address all correspondence to: jorg\_andrade@hotmail.com

1 Department of Physiology, University Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico

2 Department of Nephrology and Organ Transplant Unit, Specialties Hospital, National Occidental Medical Centre, Mexican Social Security Institute (CMNO IMSS), Guadalajara, Jalisco, Mexico

3 Department of Internal Medicine, Civil Hospital of Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico

4 Department of Nephrology, Civil Hospital of Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico
